Strengthens international IP portfolio supporting development of triple-negative breast cancer therapy through 2040 REDMOND, WA, March 18, 2026 —Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in Pattern Discovery, today announced expanded global intellectual property protection for [...]
Newly discovered drug leverages the power of Pattern Discovery Engine™ (PDE) and is an extension of 2025 study wherein Pattern developed novel risk assessment tool, discovered new drug target for Colorectal Cancer, and designed drug with genome-wide specificity for [...]
Patents and allowances extend exclusivity for investigational Triple-Negative Breast Cancer therapy to 2040 Underscores strength of proprietary PatternDE™ discovery platform REDMOND, WA, October 13, 2025 – Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in pattern discovery, [...]
Strengthens IP portfolio and supports development of triple-negative breast cancer treatment through 2040 REDMOND, Wash., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”), the global leader in pattern discovery, today announced that the Indian [...]
Working with data from the Fred Hutch Cancer Center, and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Pattern identified a novel drug target that is not actively expressed in any adult tissue, but is expressed in a [...]
Study leveraged Pattern Discovery Engine™ to construct highly accurate model to predict whether or not a given cell is cancerous Identified nine genes that are crucial for prediction and may have other uses in diagnostics and/or therapeutics Highlights use [...]
Innovative framework enhances clinician trust and transparency in AI-driven healthcare diagnostics, driving broader adoption of AI across clinical practices REDMOND, WA, March 12, 2025 – Pattern Computer®, Inc. (“Pattern” or “the Company”), a leader in cutting-edge explainable AI (XAI) research, [...]
The Pattern Discovery Engine™ and the ProSpectral™ platform will be deployed to discover new drivers of human health REDMOND, Wash., Dec. 06, 2024 -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that it has entered into a [...]
Working with data from the Fred Hutch Cancer Center, and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Pattern identified a novel drug target that is not actively expressed in any adult tissue, but is expressed in a [...]
Research collaboration leverages Pattern's ProSpectral™ multi-disease hyperspectral diagnostics research platform Potentially ushers in a new era of early detection cancer screening REDMOND, WA, August 21, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Pattern and [...]